AMIODARONE VERSUS LIDOCAINE FOR PEDIATRIC CARDIAC ARREST DUE TO VENTRICULAR ARRHYTHMIAS: A SYSTEMATIC REVIEW

Authors

  • M. Hadi Faculty of Medicine, University of Malahayati, Indonesia Author

DOI:

https://doi.org/10.53555/nnmhs.v9i7.1748

Keywords:

Lidocaine, amiodarone, cardiac arrest

Abstract

Background: Pediatric cardiac arrests are relatively uncommon but pose significant burdens. The management of pediatric cardiac arrest is unclear between amiodarone or lidocaine, necessitating further research to establish effective interventions.

Aim: to systematically review the effect and funtion of amiodarone and lidocaine, whether amiodarone is more recommended or vice versa.

Methods: this review conducted a thorough literature search comparing amiodarone and lidocaine for shock-refractory pVT/VF in children. Outcomes, including ROSC, termination of arrhythmia, and survival at discharge, were also evaluated.

Results: Out of 756 articles, only three met inclusion criteria comparing amiodarone and lidocaine for VT/VF. One adult study favored amiodarone for survival to hospital admission, but not discharge. Another study on pediatric cases showed lidocaine improved ROSC and 24-hour survival significantly. However, evidence quality was very low for both drugs, warranting further research. A small trial in adults favored amiodarone in stable VT, but its limited size and data quality pose limitations.

Conclusion: The findings of this systematic review proposes that either amiodarone or lidocaine could be considered for the treatment of pediatric shock-resistant VF/pVT.

References

Matos RI, Watson RS, Nadkarni VM, Huang HH, Berg RA, Meaney PA, et al. Duration of cardiopulmonary resuscitation and illness category impact survival and neurologic outcomes for in-hospital pediatric cardiac arrests. Circulation. 2013;127(4):442–51.

Donoghue AJ, Abella BS, Merchant R, Praestgaard A, Topjian A, Berg R, et al. Cardiopulmonary resuscitation for in-hospital events in the emergency department: A comparison of adult and pediatric outcomes and care processes. Resuscitation [Internet] 2015;92:94–100. Tersedia pada: http://dx.doi.org/10.1016/j.resuscitation.2015.04.027

De Caen AR, Berg MD, Chameides L, Gooden CK, Hickey RW, Scott HF, et al. Part 12: Pediatric Advanced Life Support 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care (Reprint). Pediatrics. 2015;136(through 2012):S176–95.

Perry JC, Fenrich AL, Hulse JE, Triedman JK, Friedman RA, Lamberti JJ. Pediatric use of intravenous amiodarone: Efficacy and safety in critically ill patients from a multicenter protocol. J Am Coll Cardiol. 1996;27(5):1246–50.

Hamilton D, Nandkeolyar S, Lan H, Desai P, Evans J, Hauschild C, et al. Amiodarone: A Comprehensive Guide for

Clinicians. Am J Cardiovasc Drugs [Internet] 2020;20(6):549–58. Tersedia pada: https://doi.org/10.1007/s40256020-00401-5

Karnina R, Arif SK, Hatta M, Bukhari A. Molecular mechanisms of lidocaine. Ann Med Surg [Internet] 2021;69(August):102733. Tersedia pada: https://doi.org/10.1016/j.amsu.2021.102733

Valdes SO, Donoghue AJ, Hoyme DB, Hammond R, Berg MD, Berg RA, et al. Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation. Resuscitation [Internet] 2014;85(3):381–6. Tersedia pada: http://dx.doi.org/10.1016/j.resuscitation.2013.12.008

Somberg JC, Bailin SJ, Haffajee CI, Paladino WP, Kerin NZ, Bridges D, et al. Intravenous Lidocaine versus intravenous Amiodarone (in a New Aqueous Formulation) for incessant ventricular tachycardia. Am J Cardiol. 2012;90(8):853–9.

As A, With C, For L, Fibrillation SV. FOR SHOCK-RESISTANT VENTRICULAR FIBRILLATION A M I O DA R O N E V E R S U S L I D O C A I N E F O R S H O C K- R E S I STA N T V E N T R I C U L A R F I B R I L L AT I O N. 2012;346(12):884–90.

Morrison LJ, Gent LM, Lang E, Nunnally ME, Parker MJ, Callaway CW, et al. Part 2: Evidence evaluation and management of conflicts of interest: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132(18):S368–82.

Holmberg MJ, Ross CE, Atkins DL, Valdes SO, Donnino MW, Andersen LW, et al. Lidocaine versus amiodarone for pediatric in-hospital cardiac arrest: An observational study. Resuscitation. 2020;149(December 2019):191–201.

Callans DJ, Gottlieb CD, Marchlinski FE. zt. 2017;830–43.

Tijssen J, DeCaen A. No shocking updates for the lidocaine vs amiodarone in pediatric pVT/VF story. Resuscitation [Internet] 2020;149:233–4. Tersedia pada: https://doi.org/10.1016/j.resuscitation.2020.02.012

Downloads

Published

2023-07-05

How to Cite

Hadi, M. (2023). AMIODARONE VERSUS LIDOCAINE FOR PEDIATRIC CARDIAC ARREST DUE TO VENTRICULAR ARRHYTHMIAS: A SYSTEMATIC REVIEW. Journal of Advanced Research in Medical and Health Science (ISSN 2208-2425), 9(7), 9-13. https://doi.org/10.53555/nnmhs.v9i7.1748

Similar Articles

11-17 of 17

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)